NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
National Institutes of Health · Chronic Diseases: Research, Control, and Prevention (93.068)
Опубликован 28 мая 2026 г. · Осталось примерно 6 месяцев
Простыми словами
Краткое описание на русском пока недоступно; показано на английском.
The US National Institutes of Health funds small US businesses to develop and commercialise health-related scientific innovations through feasibility studies and research and development projects. Applications are open from 28 May 2026 and must be submitted by 5 April 2027.
Автоматическое краткое изложение текста донора; оригинальная формулировка приведена ниже.
Краткое описание
Исходный текст донора (английский)
The Small Business Innovation Research (SBIR) program helps United States small business concerns (SBCs) bring scientific innovations to the marketplace. The SBIR program supports feasibility studies to later research and development (R&D) needed to develop a commercial product.
Фрагмент со страницы донора. Полный текст, приложения и формы — в исходном объявлении о конкурсе.
Кто может подать заявку
- Частная компания
Требования и условия
Показать требования из источника · Исходный текст донора (английский)
Applicant types: Small businesses
Only United States small business concerns (SBCs), as defined by the Small Business Administration (SBA)(sbir.gov/apply) are eligible to submit applications for this opportunity.Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Unfunded international collaborations or unfunded foreign components, as defined in the NIH Grants Policy Statement, may be allowed.